Free Trial
OTCMKTS:SPHDF

Santhera Pharmaceuticals (SPHDF) Stock Price, News & Analysis

Santhera Pharmaceuticals logo
$11.70
0.00 (0.00%)
(As of 11/4/2024 ET)

About Santhera Pharmaceuticals Stock (OTCMKTS:SPHDF)

Key Stats

Today's Range
$11.70
$11.70
50-Day Range
$11.70
$11.70
52-Week Range
$9.40
$13.35
Volume
N/A
Average Volume
400 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises Lonodelestat to treat cystic fibrosis and other neutrophilic pulmonary diseases, as well as omigapil that treats congenital muscular dystrophies. The company also out-licenses outside North America and France rights to its approved product, Raxone (idebenone), for the treatment of Leber's hereditary optic neuropathy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland.

Receive SPHDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Santhera Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SPHDF Stock News Headlines

Santhera Pharmaceuticals Holding (SANN)
Blackrock’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Santhera Pharma H1 Net Loss Narrows, Revenues Climb
See More Headlines

SPHDF Stock Analysis - Frequently Asked Questions

Santhera Pharmaceuticals' stock was trading at $11.70 on January 1st, 2024. Since then, SPHDF shares have increased by 0.0% and is now trading at $11.70.
View the best growth stocks for 2024 here
.

Santhera Pharmaceuticals shares reverse split on the morning of Monday, July 3rd 2023. The 1-10 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of SPHDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:SPHDF
CIK
N/A
Fax
N/A
Employees
45
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (OTCMKTS:SPHDF) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners